top of page
Publications
Building Out Robust Market Access Strategies Early On, Can Yield Substantial Returns on a Drug’s Commercial Success
The Great Healthcare Plan – And What It Could Mean for Players Across the Healthcare Ecosystem
340B – HRSA Pauses the Rebate Model Pilot Program, Now What?
Navigating Pricing Strategies in the Age of MFN
bottom of page